Tesamorelin

Category: GHRH analog

Studied or approved for: HIV-associated lipodystrophy (Egrifta) — narrow indication only

Regulatory status: FDA-APPROVED for that indication only; not approved for general weight loss.

Typical administration: Daily injection

Educational purposes only — not medical advice. Peptiverse.net does not sell or prescribe peptides. Consult a qualified healthcare professional. Full disclaimer: /disclaimer/.